William L. Dahut

American Cancer Society — United States

Medicine · Health Sciences

66h-index16.6kcitations524works7.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(341), Cancer, Lipids, and Metabolism(85), Cancer Immunotherapy and Biomarkers(78), Prostate Cancer Diagnosis and Treatment(72), Immunotherapy and Immune Responses(69)

Publications524 total

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4
Journal of Clinical Oncology·2026
Integrative dual ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumor transcription and resistance phenotypes in metastatic prostate cancer
2026Open Access
Abstract A038: Mechanisms of resistance to PD-L1/PARP1-targeted therapy in metastatic castration-resistant prostate cancer inferred by liquid biopsy
Cancer Research·2026
American Cancer Society’s Report on the Status of Cancer Disparities in the United States, 2025
CA A Cancer Journal for Clinicians·2025· 2 citedOpen Access
<i>CA</i> turns 75: Looking at the future but never forgetting the roots
CA A Cancer Journal for Clinicians·2025Open Access
Localized high-risk prostate cancer harbors an androgen receptor activity–low subpopulation susceptible to HER2 inhibition
Journal of Clinical Investigation·2025· 2 citedOpen Access
Prostate cancer statistics, 2025
CA A Cancer Journal for Clinicians·2025· 21 citedOpen Access
Consensus‐built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative
Cancer·2025· 2 citedOpen Access
Occupation as a firefighter and cancer mortality in a population-based cohort in the United States
International Journal of Epidemiology·2025
Improving access to cancer screening through national telehealth-based lung and colorectal cancer screening programs.
Journal of Clinical Oncology·2025
Abstract LB349: Mechanisms of resistance to PD-L1/PARP1-targeted therapy in metastatic castration-resistant prostate cancer inferred by liquid biopsy
Cancer Research·2025
IP05-10 Comparison of 18F-DCFPyL PSMA PET/CT uptake to PSMA protein expression in high-risk prostate tumors from the NCI Prostate Moonshot study
The Journal of Urology·2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients
Oncotarget·2025· 2 citedOpen Access
PSMA-based PET imaging in newly diagnosed, high-risk localized prostate cancer, a National Cancer Institute (NCI) Cancer Moonshot trial.
Journal of Clinical Oncology·2025
Association of localized high-risk prostate cancer (PC) and an androgen receptor low subpopulation susceptible to HER2 inhibition.
Journal of Clinical Oncology·2025
<i>TMPRSS2-ERG</i> confers resistance to antiandrogens: mechanism and therapeutic implications
2025Open Access
Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States
Cancer Biomarkers·2025· 1 citedOpen Access
Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update
European Urology·2024· 113 citedOpen Access
What’s in a Name? Why Words Matter in Advanced Prostate Cancer
European Urology·2024· 2 cited
Abstract A125: A nationwide initiative to expand access to lung cancer screening: Results and impact of the Color/American Cancer Society Lung Screening Access Program
Cancer Epidemiology Biomarkers & Prevention·2024
page 1 of 27Next →

Frequent Co-authors

James L. Gulley(30), Seth M. Steinberg(25), Philip M. Arlen(22), William D. Figg(16), Jeffrey Schlom(15), James R. Wright(10), Ravi A. Madan(10), Howard L. Parnes(9), Elizabeth C. Jones(9), William D. Figg(7), Jennifer L. Marté(6), Diane J. Poole(6), Kwong-Yok Tsang(6), Jeanny B. Aragon‐Ching(6), Lokesh Jain(6), Clara C. Chen(5), Mary Pazdur(5), Jane B. Trepel(5), Alex Sparreboom(5), Tristan M. Sissung(5)